CRVS Corvus Pharmaceuticals, Inc. PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Corvus Pharmaceuticals (CRVS) Stock: Buy, Sell, or Hold?

$11.34
-0.03 (-0.26%) ▼
5d: +7.28% 30d: +20.51% 90d: -25.1%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (35%)
Quality Score
33/100
Position
EXTENDED
30-Day Fair Range
$9.75 – $10.82
Position: EXTENDED
Forward P/E & Valuation
-10.4x
Next 12M consensus est.
Wall Street Target
$31.50
+177.0% upside
Options IV & Volume
36th pct IV
HIGH volume confirmation
Support / Resistance
$9.58 / $11.78
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CRVS shows conflicting indicators. Wait for confirmation before entering.
Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Nov 5, 2026 at $10.48 · last confirmed Nov 9, 2026

Strength: 8.4/10

Get Alerted When CRVS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: CRVS is currently trading at $11.34, which is considered extended relative to its 30-day fair value range of $9.75 to $10.82.

Technical Outlook: Technically, CRVS is in a strong downtrend. Immediate support is located at $9.58, while resistance sits at $11.78.

Market Sentiment: CRVS scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $31.50 (+177.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $9.75 - $10.82
Company Quality Score 33/100 (SELL)
Options IV Signal 36th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 35.4%

Trading Range & Key Levels

30-Day Trading Range $9.75 - $10.82
Current vs Trading Range EXTENDED
Expected Move (7 Days) ±$1.39 (12.2%)
Support Level $9.58
Resistance Level $11.78
Current Trend Strong Downtrend
Technical data as of Nov 10, 2026

Protect Your Profits

Holding CRVS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BEARISH: Price extended above range
  • NEUTRAL: Options fairly priced (IV 36th percentile)
  • BEARISH: Weak technical setup (23/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 177.0% below Wall St target ($31.50)
  • WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -10.43
Wall Street Target $31.50 (+177.0%)
Share CRVS Analysis

Share this live CRVS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (CRVS)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages indicate bullish sentiment towards $CRVS, with one user praising Miller's leadership as resembling a research lab with no commercial consequences.
Key Retail Themes: Bullish sentiment towards $CRVS leadership
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 10:39 AM ET
Data refreshes hourly during market hours. Next update: 11:39 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CRVS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$302 55 HOLD
VRTX
Vertex Pharmaceuticals I…
STRONG BUY
32 analysts
$592 37 SELL
ONC
BeOne Medicines AG
STRONG BUY
27 analysts
$438 35 SELL
ORIC
Oric Pharmaceuticals Inc
STRONG BUY
15 analysts
$22 72 BUY
TVTX
Travere Therapeutics Inc
STRONG BUY
15 analysts
$75 66 BUY

Advanced CRVS Option Strategies

Professional options setups generated by AI based on today's CRVS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive CRVS Research Pages
CRVS Technical Chart CRVS Price Prediction CRVS Intrinsic Value DCF CRVS Earnings Date CRVS Investment Advisor CRVS Fair Price Analyzer CRVS Options Chain CRVS Options Advisor CRVS Options Analysis CRVS Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals